Comprising 26 chapters, this volume deals with the genetic transformation of medicinal plants. It describes methods to obtain plants resistant to insects, diseases, herbicides, and plants with an increased production of compounds of medicinal and pharmaceutical importance. The plant species included are Ajuga reptans, Anthemis nobilis, Astragalus spp., Atropa belladonna, Catharanthus roseus, Datura spp., Duboisia leichhardtii, Fagopyrum spp., Glycyrrhiza uralensis, Lobelia spp., Papaver somniferum, Panax ginseng, Peganum hamala, Perezia spp., Pimpinella anisum, Phyllanthus niruri, Salvia miltiorrhiza, Scoparia dulcis, Scutellaria baicalesis, Serratula tinctoria, Solanum aculeatissimum, Solanum commersonii, Swainsona galegifolia, tobacco, and Vinca minor. The book is of special interest to advanced students, teachers, and researchers in the fields of pharmacy, plant tissue culture, phytochemistry, molecular biology, biomedical engineering, and plant biotechnology in general.

Contains case studies illustrating the cell culture production of pigments, flavors, and antineoplastic compounds Plant Biotechnology and Transgenic Plants covers topics that range from food to fragrances to fuel. It includes discussions of technologies and research on the engineering, synthesis, utilization, and control of primary and secondary plant metabolites such as carbohydrates, amino acids, lipids, polymers, proteins, and phytochemicals for industrial, pharmaceutical, and food and feed applications. The editors put the emphasis on recent methods in farming, plant propagation, and breeding and modern procedures to formulate more effective biopharmaceuticals.

From the beginning of human civilization, people have depended on plants to cure disease, promote healing of injuries, and alleviate pain. In many places that has changed very little. In the West, however, herbal and botanical cures have long been ignored in favor of "scientific medicine." But the benefits of medicinal plants are being rediscovered in many developed countries, where consumers are turning to such therapies in place of, and in addition to, Western medical treatments. And, all over the world, the drive to lower the cost of health care has made herbals and botanicals an attractive alternative to more expensive synthetic remedies. In 1978, the World Health Organization responded to increased interest in medicinal plants by convening a series of international consultations, seminars, and symposia to explore and promote the use of medicinal plants. Medicinal Plants presents the proceedings of the last of these symposia, held in 1993. It brings together an vast range of information and presents an overview of the use of medicinal plants that includes a discussion of a variety of issues—scientific, economic, regulatory, agricultural, cultural—focused on the importance of medicinal plants to primary health care and global health care reform.

Plant-based medicines play an important role in all cultures, and have been indispensable in maintaining health and combating diseases. The identification of active principles and their molecular targets from traditional medicine provides an enormous opportunity for drug development. Using modern biotechnology, plants with specific chemical compositions can be mass propagated and genetically improved for the extraction of bulk active pharmaceuticals. Although there has been significant progress in the use of biotechnology, using tissue cultures and genetic transformation to investigate and alter pathways for the biosynthesis of target metabolites, there are many challenges involved in bringing plants from the laboratory to successful commercial cultivation. This book presents the latest advances in the development of medicinal drugs, including topics such as plant tissue cultures, secondary metabolite production, metabolomics, metabolic engineering, bioinformatics and future biotechnological directions.

Ex situ preservation of germplasm for higher plant species has been accom plished using either seeds or clones, but storage of these under typical condi tions does not provide the extreme longevities that are needed to minimize risk of loss. Costs of maintenance and regeneration of stocks are also high. Systems that provide virtually indefinite storage should supplement existing methods and it is within this context that cryopreservation is presented. The use of low temperature preservation was initially more a concern of medicine and animal breeding, and was expanded to plants in the 1970s. Sur vival after cryogenic exposure has now been demonstrated for diverse plant groups including algae, bryophytes, fungi and higher plants. If survival is com monplace, then the eventual application is a cryopreservation system, whereby cells, tissues and organs are held indefinitely for use, often in the unforeseen future. The increasing interest and capabilities for application could not have occurred at a more opportune time since expanding human populations have placed unprecedented pressures on plant diversity. This book emphasizes cry opreservation of higher plants and was initially driven by the concern for loss of diversity in crops and the recognized need that this diversity would be essential for continued improvement of the many plants used by society for food, health and shelter. The interest in cryopreservation has been expanded by conservationists and their concerns for retaining, as much as possible, the diversity of natural populations. The need for cryopreservation, thus, is well established.

Successful release of new and better crop varieties increasingly requires genomics and molecular biology. This volume presents basic information on plant molecular marker techniques from marker location up to gene cloning. The text includes a description of technical approaches in genome analysis such as comparison of marker systems, positional cloning, and array techniques in 19 crop plants.

This book is a collection of chapters concerning the use of biomass for the sustainable production of energy and chemicals–an important goal that will help decrease the production of greenhouse gases to help mitigate global warming, provide energy security in the face of dwindling petroleum reserves, improve balance of payment problems and spur local economic development. Clearly there are ways to save energy that need to be encouraged more. These include more use of energy sources such as, among others, manure in anaerobic digesters, waste wood in forests as fuel or feedstock for cellulosic ethanol, and conservation reserve program (CRP) land crops that are presently unused in the US. The use of biofuels is not new; Rudolf Diesel used peanut oil as fuel in the ?rst engines he developed (Chap. 8), and ethanol was used in the early 1900s in the US as automobile fuel [Songstad et al. (2009) Historical perspective of biofuels: learning from the past to rediscover the future. In Vitro Cell Dev Biol Plant 45:189–192). Brazil now produces enough sugar cane ethanol to make up about 50% of its transportation fuel needs (Chap. 4). The next big thing will be cellulosic ethanol. At present, there is also the use of Miscanthus x giganteous as fuel for power plants in the UK (Chap. 2), bagasse (sugar cane waste) to power sugar cane mills (Chap. 4), and waste wood and sawdust to power sawmills (Chap. 7).

Here is an informative overview of diabetes mellitus in conjunction with plant-based treatments. It discusses available methods for studying the antidiabetic activities of scientifically developed plant products, mechanisms of action, their therapeutic superiority, and current genome editing research perspectives and biotechnological approaches. The book begins with an introduction to diabetes, giving a brief overview of the history, diagnosis, classification, pathophysiology, and risk factors. It goes on to review traditional uses of plants for diabetes along with ethnobotanical information. The results of scientific studies on the various modes of action of antidiabetic plants are discussed, such as the molecular aspects of active plantbased antidiabetic drug molecules. A section featuring recent biotechnological advancements of antidiabetic plants and plant-based antidiabetic drugs covers advances in molecular breeding and application of molecular markers, biotechnologically engineered transgenic medicinal plants, and advances in genomic editing tools and techniques.

This volume comprising 28 chapters on the in vitro manipulation of plant protoplasts contributed by inter- national experts deals with the isolation, fusion, culture, immobilization, cryopreservation and ultrastructural studies on protoplasts and the regeneration of somatic hybrids and cybrids.

The book provides an overview of current trends in biotechnology and medicinal plant sciences. The work includes detailed chapters on various advance biotechnological tools involved in production of phytoactive compounds of medicinal significance. Some recent and novel research studies on therapeutic applications of different medicinal plants from various geographical regions of the world have also been included. These studies report the antimicrobial activity of various natural plant products against various pathogenic microbial strains. Informative chapters on recent emerging applications of plant products such as source for nutraceuticals and vaccines have been integrated to cover latest advances in the field. This book also explores the conservation aspect of medicinal plants. Thus, chapters having comprehensively complied in vitro conservation protocols for various commercially important rare, threatened and endangered medicinal plants were provided in the present book.